welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
withdrawn
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
study id #: NCT00026468
condition: Colorectal Cancer, Small Intestine Cancer
status: withdrawn
purpose:RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
intervention: Drug: exisulind
study details
study contacts
expertly curated content related to this topic
-
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Ad...Evidence supporting aspirin and resistan...
-
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal CancersPrimary Objective: - To determine whethe...
-
Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous PolyposisA Phase 2, randomized, double blind, pla...
-
How to Care for Your Stoma After an OstomyThe days that follow your colostomy proc...
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomicsBackground: Saliva, blood, tissue, and ...
-
Rectal Proliferation and Polyp Occurrence in Pateints with Familial Adenomatous Polyposis after Sulindac TreatmentBACKGROUND/AIMS : Sulindac, a nonsteroid...
-
Familial Adenomatous PolyposisFamilial adenomatous polyposis is an inh...
English
Portuguese
Spanish